These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 34526667)
1. Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections. Bandyopadhyay D; Mukherjee M J Antibiot (Tokyo); 2022 Jan; 75(1):21-28. PubMed ID: 34526667 [TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli. Bandyopadhyay D; Mukherjee M Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1753-1760. PubMed ID: 32399681 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565 [TBL] [Abstract][Full Text] [Related]
4. Treating urinary tract infections due to MDR E. coli with Isothiocyanates - a phytotherapeutic alternative to antibiotics? Mutters NT; Mampel A; Kropidlowski R; Biehler K; Günther F; Bălu I; Malek V; Frank U Fitoterapia; 2018 Sep; 129():237-240. PubMed ID: 30031115 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study. Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700 [TBL] [Abstract][Full Text] [Related]
6. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Blango MG; Mulvey MA Antimicrob Agents Chemother; 2010 May; 54(5):1855-63. PubMed ID: 20231390 [TBL] [Abstract][Full Text] [Related]
7. Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic Rozwadowski M; Gawel D Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011308 [TBL] [Abstract][Full Text] [Related]
9. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617 [TBL] [Abstract][Full Text] [Related]
10. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli. Javed S; Mirani ZA; Pirzada ZA Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131. de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601 [TBL] [Abstract][Full Text] [Related]
12. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Chen YT; Ahmad Murad K; Ng LS; Seah JT; Park JJ; Tan TY Ann Acad Med Singap; 2016 Jun; 45(6):245-50. PubMed ID: 27412057 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Jalil MB; Al Atbee MYN J Clin Lab Anal; 2022 Sep; 36(9):e24619. PubMed ID: 35870190 [TBL] [Abstract][Full Text] [Related]
15. Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an Kerkez I; Tulkens PM; Tenson T; Van Bambeke F; Putrinš M Antimicrob Agents Chemother; 2021 Nov; 65(12):e0146821. PubMed ID: 34570646 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Characterization of Carbon Dots Coated CaCO Kanwal A; Uzair B; Sajjad S; Samin G; Ali Khan B; Khan Leghari SA; Khan Niazi MB; Abbas S Microb Drug Resist; 2022 Jan; 28(1):106-119. PubMed ID: 34402682 [TBL] [Abstract][Full Text] [Related]
17. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba. Regasa Dadi B; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W J Infect Dev Ctries; 2018 Aug; 12(8):608-615. PubMed ID: 31958322 [TBL] [Abstract][Full Text] [Related]
18. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae. So W; Crandon JL; Nicolau DP J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857 [TBL] [Abstract][Full Text] [Related]
19. Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci. Dang TN; Zhang L; Zöllner S; Srinivasan U; Abbas K; Marrs CF; Foxman B Infect Genet Evol; 2013 Oct; 19():212-8. PubMed ID: 23891665 [TBL] [Abstract][Full Text] [Related]
20. Virulence Genes and Antibiotic Susceptibilities of Uropathogenic E. coli Strains. Uzun C; Oncül O; Gümüş D; Alan S; Dayioğlu N; Küçüker MA Clin Lab; 2015; 61(8):941-50. PubMed ID: 26427137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]